Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Goossen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Urology Case Reports|July 2, 2026
Primary bulbar urethral adenocarcinoma arising from intestinal-type villous adenoma: a rare malignant entityRachel Cockburn, Jennifer Xu, Hans Goossen
Australian Journal of General Practice|May 2, 2024
Urological focus on gender affirmation surgeryDavid Homewood, Caitlin Kennedy, Hans Goossen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2015
A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancerRebecca L Prue, Frank Vari, Kristen J Radford, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Urology Case Reports|July 2, 2026
Primary bulbar urethral adenocarcinoma arising from intestinal-type villous adenoma: a rare malignant entityRachel Cockburn, Jennifer Xu, Hans Goossen
Australian Journal of General Practice|May 2, 2024
Urological focus on gender affirmation surgeryDavid Homewood, Caitlin Kennedy, Hans Goossen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2015
A phase I clinical trial of CD1c (BDCA-1)+ dendritic cells pulsed with HLA-A*0201 peptides for immunotherapy of metastatic hormone refractory prostate cancerRebecca L Prue, Frank Vari, Kristen J Radford, et al.
Pageof 1